Replies to post #5854 on GW Pharmaceuticals Plc ADS (GWPH)

[john1311]

Greenwich Biosciences, Inc., a Subsidiary of GW Pharmaceuticals plc, Launches unspoken symphony, a Breakthrough Innovation Created for the US Epilepsy Community

CARLSBAD, Calif., Oct. 21, 2020 (GLOBE NEWSWIRE) -- Greenwich Biosciences, Inc., the US leader in the field of cannabinoid prescription medicines and subsidiary of GW Pharmaceuticals plc (Nasdaq: GWPH), today announced the launch of unspoken symphony, a web-based, image-recognition technology that gives individuals with epilepsy who struggle to express themselves verbally a new way to communicate and connect like never before by translating artwork into a melody. Many people living with epilepsy may experience developmental delays or cognitive impairment in addition to seizures, making it challenging to verbalize or connect with others. This is particularly common in seizure conditions such as Lennox-Gastaut syndrome (LGS), Dravet syndrome and tuberous sclerosis complex (TSC).i,ii Often, individuals with limited verbal ability turn to art and/or music therapy as a way to express themselves. unspoken symphony offers a unique way to bridge the two.

https://ir.gwpharm.com/news-releases/news-release-details/greenwich-biosciences-inc-subsidiary-gw-pharmaceuticals-plc